As technology advances and choices grow, you need to personalize patients’ options.

Teplizumab may work by binding to certain immune system cells that attack insulin-producing cells and increase the proportion of cells that help moderate the immune response, thus delaying progression to stage 3 type 1 diabetes.

Increasing scleral lens use can benefit a larger patient base.

Combining products and resources in creative ways can help grow your business.

Glaucoma therapy isn't as cookie-cutter as it seems on the surface.

Ocuphire seeks to develop and commercialize Nyxol for the reversal of mydriasis, presbyopia and night vision disturbances.

The submission of 24-month efficacy data from DERBY and OAKS is classified as a Major Amendment to the New Drug Application, which delays the PDUFA target action date until February 2023.

The main outcome measures were the baseline cataract severity and self-reported cataract surgery at a 15-year visit.

Preservative-free eye drops offer benefits for ocular health.

Enhanced treatments, tools, and resources make a difference.

Advanced planning is the key for the most successful practice transitions as well as realizing the highest return on investment on the sale.

The CHAMP phase 3 study shows strong safety and efficacy of NVK002 for the treatment of myopia.

Optometrists may be the first, or only, touchpoint that patients have with the healthcare system.

When interpreting study findings, take into consideration the similarity and the differences between the subjects recruited for the study versus the patient population each practitioner serves.

Presbyopia-correcting drops for patients with low, up-close visual function.

Obesity can affect retinal structures differently.

This research collaboration between Chinese and Australian researchers set out to investigate the connection in the UK Biobank Study cohort.

Evolution of vision correction procedures, diagnostics paves way for collaborative care.

It was reported that the more individuals smoke, the faster the retinal nerve fiber layer (RNFL) becomes thinner.

Awareness of visual impairment in clinical practice is suboptimal, and adherence to ophthalmologic evaluation needs to be improved. The prospective cohort study in the Netherlands included 170 children aged 0 to 18 years with a newly diagnosed brain tumor.